UA91197C2 - Вакцинная композиция для иммунизации собак против leptospira bratislava - Google Patents

Вакцинная композиция для иммунизации собак против leptospira bratislava

Info

Publication number: UA91197C2
Authority: UA; Ukraine
Prior art keywords: canine; caused; leptospira; vaccine; dogs against
Prior art date: 2004-10-06

Application number

UAA200703828A

Other languages

English (en)

Ukrainian (uk)

Inventor

Джозеф Франц

Томас Джек Ньюбай

Кассиус МакАллистер Таккер

Original Assignee

Пфайзер Продактс Инк.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-06

Filing date

2005-09-23

Publication date

2010-07-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA91197(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-23 Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.

2010-07-12 Publication of UA91197C2 publication Critical patent/UA91197C2/ru

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

UAA200703828A 2004-10-06 2005-09-23 Вакцинная композиция для иммунизации собак против leptospira bratislava UA91197C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/959,757 US20050089533A1 (en)	2003-01-29	2004-10-06	Canine vaccines against Bordetella bronchiseptica

Publications (1)

Publication Number	Publication Date
UA91197C2 true UA91197C2 (ru)	2010-07-12

Family

ID=35657262

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200703828A UA91197C2 (ru)	2004-10-06	2005-09-23	Вакцинная композиция для иммунизации собак против leptospira bratislava

Country Status (26)

Country	Link
US (2)	US20050089533A1 (ru)
EP (1)	EP1799253B1 (ru)
JP (2)	JP4163245B2 (ru)
KR (3)	KR20070050499A (ru)
CN (2)	CN101035558B (ru)
AT (1)	ATE524193T1 (ru)
AU (1)	AU2005290921C1 (ru)
BR (1)	BRPI0516253A (ru)
CA (1)	CA2583689C (ru)
CY (1)	CY1114897T1 (ru)
DK (1)	DK1799253T3 (ru)
ES (1)	ES2370750T3 (ru)
HK (1)	HK1112839A1 (ru)
LU (2)	LU92135I2 (ru)
ME (1)	ME01306B (ru)
MX (1)	MX2007004133A (ru)
NO (1)	NO20071385L (ru)
NZ (3)	NZ591422A (ru)
PL (1)	PL1799253T3 (ru)
PT (1)	PT1799253E (ru)
RS (1)	RS52035B (ru)
RU (1)	RU2400248C2 (ru)
SI (1)	SI1799253T1 (ru)
UA (1)	UA91197C2 (ru)
WO (1)	WO2006038115A1 (ru)
ZA (1)	ZA200702166B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
ME00485B (me) *	2005-10-07	2011-10-10	Zoetis Services Llc	VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA
US7468187B2 (en) *	2005-10-18	2008-12-23	Iowa State University Research Foundation, Inc.	Canine influenza virus and related compositions and methods of use
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
EP2062972A4 (en) *	2006-09-13	2010-11-24	Nippon Zenyaku Kogyo Co Ltd	NEW DOG VACCINE
MX2009004866A (es) *	2006-11-03	2009-05-19	Schering Plough Ltd	Vacuna para enfermedad de lyme canina.
US20100028379A1 (en) *	2006-12-27	2010-02-04	Pfizer, Inc	Methods of vaccine administration
AU2015255165A1 (en) *	2006-12-27	2015-11-26	Zoetis Services Llc	Methods of vaccine administration
JP5470052B2 (ja)	2007-02-27	2014-04-16	ゾエティス・ダブリュー・エルエルシー	動物の感染症を治療または予防するための免疫原組成物
US7878586B2 (en) *	2007-10-29	2011-02-01	The Boeing Company	System and method for an anticipatory passenger cabin
CA2710186C (en)	2007-12-21	2015-11-03	Pfizer Inc.	Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
CA2777692A1 (en)	2009-10-14	2011-04-21	Sanjay Kapil	Isolation of a virus related to canine parvovirus-2 from a raccoon
CN103153337A (zh)	2010-09-28	2013-06-12	共立制药股份有限公司	黏膜佐剂组合物
CA2826058C (en) *	2011-02-04	2017-06-06	Zoetis Llc	Compositions for canine respiratory disease complex
PL2670432T3 (pl) *	2011-02-04	2021-10-11	Zoetis Services Llc	Kompozycje immunogenne Bordetella bronchiseptica
CN102343088B (zh) *	2011-10-14	2013-02-13	浙江诺倍威生物技术有限公司	一种犬传染性气管支气管炎二联活疫苗及其制备方法
BR112015003074A2 (pt)	2012-08-17	2017-07-04	Intervet Int Bv	composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
AU2013304048B2 (en) *	2012-08-17	2018-03-01	Intervet International B.V.	An immunogenic composition of killed Leptospira bacteria
US9314519B2 (en) *	2012-08-21	2016-04-19	Intervet Inc.	Liquid stable virus vaccines
CZ307883B6 (cs) *	2013-01-29	2019-07-24	Bioveta, A.S.	Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) *	2013-06-06	2015-04-10	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko)	2014-07-16	2016-05-19	(주)양성그린바이오	면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (en)	2020-09-28	2021-11-17	Institute of Life Sciences (ILS)	Whole cell livestock vaccine for respiratory diseases
CN117187118A (zh) *	2023-08-16	2023-12-08	华中农业大学	一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3470294A (en) *	1961-06-21	1969-09-30	Behringwerke Ag	Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567042A (en) *	1983-06-15	1986-01-28	American Home Products Corporation	Inactivated canine coronavirus vaccine
US4567043A (en) *	1983-06-15	1986-01-28	American Home Products Corporation (Del.)	Canine corona virus vaccine
US4888169A (en) *	1986-10-14	1989-12-19	Norden Laboratories, Inc.	Bordetella Bronchiseptica vaccine
JP2521226B2 (ja) *	1993-01-28	1996-08-07	株式会社微生物化学研究所	犬用多種混合ワクチン
ATE224202T1 (de) *	1993-03-31	2002-10-15	Univ California	Cloniertes protein der äusseren membran von leptospira
UA56132C2 (ru) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиция вакцины (варианты), способ стабилизации qs21 по отношению к гидролизу (варианты), способ приготовления вакцины
AUPO549497A0 (en) *	1997-03-07	1997-03-27	Agriculture Victoria Services Pty Ltd	Novel bacterial pathogens
US6306623B1 (en) *	1998-02-24	2001-10-23	The University Of California	Leptospiral major outer membrane protein LipL32
NZ501213A (en) *	1998-12-22	2001-09-28	Pfizer Prod Inc	Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) *	2000-04-27	2002-05-16	Coyne Michael J.	Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) *	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
AU2002308453B2 (en) *	2002-05-17	2009-12-03	Fundacao Oswaldo Cruz-Fiocruz	Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species
OA12915A (en) *	2002-08-26	2006-10-13	Pfizer Prod Inc	Vaccine for respiratory and reproductive system infections in cattle.
BRPI0407032A (pt) *	2003-01-29	2006-01-17	Pfizer Prod Inc	Vacinas caninas contra bordetella bronchiseptica
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
US20100028379A1 (en) *	2006-12-27	2010-02-04	Pfizer, Inc	Methods of vaccine administration

2004
- 2004-10-06 US US10/959,757 patent/US20050089533A1/en not_active Abandoned
2005
- 2005-09-23 NZ NZ591422A patent/NZ591422A/xx not_active Application Discontinuation
- 2005-09-23 AT AT05789769T patent/ATE524193T1/de active
- 2005-09-23 WO PCT/IB2005/003111 patent/WO2006038115A1/en active Application Filing
- 2005-09-23 NZ NZ576898A patent/NZ576898A/en not_active Application Discontinuation
- 2005-09-23 CN CN2005800341946A patent/CN101035558B/zh active Active
- 2005-09-23 JP JP2007535271A patent/JP4163245B2/ja active Active
- 2005-09-23 NZ NZ553867A patent/NZ553867A/en not_active Application Discontinuation
- 2005-09-23 DK DK05789769.6T patent/DK1799253T3/da active
- 2005-09-23 MX MX2007004133A patent/MX2007004133A/es active IP Right Grant
- 2005-09-23 RU RU2007112480/13A patent/RU2400248C2/ru active
- 2005-09-23 BR BRPI0516253-0A patent/BRPI0516253A/pt not_active Application Discontinuation
- 2005-09-23 PL PL05789769T patent/PL1799253T3/pl unknown
- 2005-09-23 ME MEP-2011-192A patent/ME01306B/me unknown
- 2005-09-23 ES ES05789769T patent/ES2370750T3/es active Active
- 2005-09-23 UA UAA200703828A patent/UA91197C2/ru unknown
- 2005-09-23 AU AU2005290921A patent/AU2005290921C1/en not_active Expired
- 2005-09-23 SI SI200531376T patent/SI1799253T1/sl unknown
- 2005-09-23 KR KR1020077008111A patent/KR20070050499A/ko not_active Application Discontinuation
- 2005-09-23 KR KR1020127000574A patent/KR101226869B1/ko active IP Right Grant
- 2005-09-23 CN CN200910226561A patent/CN101791398A/zh active Pending
- 2005-09-23 KR KR1020087025748A patent/KR20080096610A/ko not_active Application Discontinuation
- 2005-09-23 EP EP05789769A patent/EP1799253B1/en active Active
- 2005-09-23 RS RS20110497A patent/RS52035B/en unknown
- 2005-09-23 PT PT05789769T patent/PT1799253E/pt unknown
- 2005-09-23 CA CA2583689A patent/CA2583689C/en active Active
2007
- 2007-03-14 ZA ZA200702166A patent/ZA200702166B/xx unknown
- 2007-03-15 NO NO20071385A patent/NO20071385L/no unknown
- 2007-12-21 US US11/962,699 patent/US20080175860A1/en not_active Abandoned
2008
- 2008-02-22 HK HK08101940.1A patent/HK1112839A1/xx unknown
- 2008-04-15 JP JP2008105332A patent/JP2008239627A/ja active Pending
2011
- 2011-10-17 CY CY20111100986T patent/CY1114897T1/el unknown
2013
- 2013-01-16 LU LU92135C patent/LU92135I2/fr unknown
- 2013-01-16 LU LU92136C patent/LU92136I2/fr unknown

Also Published As

Publication number	Publication date
LU92135I2 (fr)	2013-03-18
LU92136I9 (ru)	2019-01-04
CN101791398A (zh)	2010-08-04
ME01306B (me)	2013-12-20
AU2005290921B2 (en)	2010-07-08
KR20120031294A (ko)	2012-04-02
CY1114897T1 (el)	2016-12-14
ZA200702166B (en)	2008-11-26
HK1112839A1 (en)	2008-09-19
RU2007112480A (ru)	2008-11-20
NZ553867A (en)	2010-10-29
CA2583689A1 (en)	2006-04-13
KR20070050499A (ko)	2007-05-15
DK1799253T3 (da)	2011-11-28
NZ591422A (en)	2012-09-28
SI1799253T1 (sl)	2011-11-30
LU92136I2 (fr)	2013-03-18
ATE524193T1 (de)	2011-09-15
NZ576898A (en)	2011-03-31
EP1799253A1 (en)	2007-06-27
PL1799253T3 (pl)	2012-01-31
RU2400248C2 (ru)	2010-09-27
CN101035558B (zh)	2011-04-06
JP2008515873A (ja)	2008-05-15
NO20071385L (no)	2007-04-18
JP4163245B2 (ja)	2008-10-08
RS52035B (en)	2012-04-30
KR20080096610A (ko)	2008-10-30
LU92135I9 (ru)	2019-01-04
AU2005290921C1 (en)	2012-10-11
ES2370750T3 (es)	2011-12-22
CN101035558A (zh)	2007-09-12
WO2006038115A1 (en)	2006-04-13
EP1799253B1 (en)	2011-09-14
MX2007004133A (es)	2007-06-15
JP2008239627A (ja)	2008-10-09
US20050089533A1 (en)	2005-04-28
US20080175860A1 (en)	2008-07-24
BRPI0516253A (pt)	2008-08-26
AU2005290921A1 (en)	2006-04-13
CA2583689C (en)	2013-06-11
KR101226869B1 (ko)	2013-01-25
PT1799253E (pt)	2011-11-10

Publication	Publication Date	Title
UA91197C2 (ru)	2010-07-12	Вакцинная композиция для иммунизации собак против leptospira bratislava
TW200505476A (en)	2005-02-16	Canine vaccines against bordetella bronchiseptica
HRP20050192B1 (hr)	2014-02-14	Cjepivo za infekcije dišnog i spolnog sustava kod goveda
AR064530A1 (es)	2009-04-08	Procedimientos para la administracion de vacunas
WO2004096993A3 (en)	2009-03-26	Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
WO2003072719A3 (en)	2007-09-13	Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
RU2006140984A (ru)	2008-05-27	Вакцина против пародонтоза
WO2004093904A3 (en)	2004-12-23	Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles
McFarland et al.	2011	Non-animal replacement methods for human vaccine potency testing: state of the science and future directions
CA2533877A1 (en)	2005-03-10	Safe mutant viral vaccines
RU2006133328A (ru)	2008-03-27	Способ вакцинации против инфекции семенников bvdv
AU3887695A (en)	1996-05-02	Interleukin-12 as an adjuvant for paramyxoviridae vaccines
WO2008106393A3 (en)	2008-12-04	Immunogenic compositions and methods for treating and preventing animal infections
Gingerich et al.	2023	A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice
NZ595748A (en)	2013-07-26	Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
Gingerich et al.	2024	Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year
CO5690616A2 (es)	2006-10-31	Vacunas para enfermedades reproductoras del ganado
TH94300A (th)	2009-03-13	องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้